PMOS Linked to Alzheimer’s Disease Risk: What You Need to Know
Recent research has identified a potential connection between Polyendocrine Metabolic Ovarian Syndrome (PMOS), previously known as Polycystic Ovary Syndrome (PCOS), and changes in cognitive function that may overlap with Alzheimer’s disease. A review published in the *Journal of the Endocrine Society* suggests that metabolic conditions associated with PMOS, rather than the syndrome itself, could help explain this relationship.
Researchers have been investigating the role of metabolic factors, such as insulin resistance, obesity, type 2 diabetes, and high cholesterol, in the cognitive decline often associated with dementia. Dr. Yesika Garcia, a board-certified endocrinologist, emphasizes that while PMOS may be linked to certain cognitive changes, it is essential to understand that these metabolic issues are likely the primary contributors to any increased risk of dementia.
The review analyzed various studies examining brain structure and cognitive performance in individuals diagnosed with PMOS. It revealed that those with PMOS might experience subtle differences in cognitive abilities, including executive function, working memory, processing speed, and word recognition. Brain imaging studies have also indicated variations in brain structure and function among PMOS patients, particularly in relation to hormonal changes that affect gray matter.
Interestingly, the review found that cognitive differences were less significant when PMOS individuals were compared to metabolically healthy control groups, reinforcing the idea that associated metabolic conditions are crucial to understanding the connection between PMOS and brain health.
Despite these findings, researchers caution against jumping to conclusions. Dr. Dung Trinh, a medical expert in cognitive health, stresses the importance of further research to determine if PMOS itself independently increases the risk of Alzheimer’s disease. He notes that the link between metabolic health and brain function is increasingly recognized, highlighting the need for more attention and study on PMOS in relation to cognitive decline.
The research identifies several overlapping pathways between PMOS and dementia, including obesity, insulin resistance, dyslipidemia, gut dysbiosis, sleep disturbances, and alterations in sex hormones. Insulin resistance, in particular, is viewed as a critical factor since insulin is essential for both metabolic and brain function. Impaired insulin signaling can disrupt how brain cells utilize energy, potentially leading to memory and cognitive issues over time.
To mitigate risks associated with cognitive decline, experts recommend adopting strategies to improve metabolic health. Regular physical activity, including both cardiovascular and strength training, can enhance insulin sensitivity and support overall health. A balanced diet, particularly a Mediterranean-style diet rich in fruits, vegetables, whole grains, and healthy fats, is also beneficial.
Additionally, managing blood sugar, cholesterol levels, and blood pressure is vital. Some medications, such as metformin, may improve insulin resistance and further reduce dementia risk. Maintaining adequate sleep, avoiding smoking, and staying mentally and socially active can also contribute to long-term brain health.
Dr. Garcia advises individuals with PMOS to maintain regular check-ups with healthcare providers to monitor their metabolic health and address any emerging issues early. While it remains unclear whether specific interventions can prevent dementia in women with PMOS, adopting a holistic approach to health is beneficial for both metabolic and cognitive well-being.
